Mariano García-Valiño

Mr. Mariano García-Valiño has been appointed to the Company’s Board of Directors in January 2019. Mr. García-Valiño has been active at the intersection of healthcare, strategy, and entrepreneurship for over 25 years. Most recently, Mr. García-Valiño was CEO of GBT (B3:GBIO33), a biopharmaceutical player with a presence in ten markets, which he architected, launched and took public in 2017. Mr. Garcia-Valiño holds an Engineering degree from Universidad de Buenos Aires and an MBA from the Harvard Business School.